The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its anti-inflammatory drug Dupixent, as well as newer treatments and vaccines.

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

Explore QuantumScape's Q1 2025 earnings call insights, featuring progress on solid-state battery tech, Cobra process milestones, and partnerships ...

Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...

President Donald Trump says he plans to impose tariffs on pharmaceuticals "very shortly ... when the import taxes could take effect and what products, if any, may be spared.

Trump’s proposed tariffs on pharma products are still under investigation, with an announcement expected soon, while some companies are stockpiling medicines to prepare for potential impacts. LONDON, ...

Trump also threatened duties on Friday after his first set of "reciprocal" tariffs exempted pharmaceutical products. Trump has not said when and by how much he plans to raise levies on ...

The U.S. exported $144 billion worth of products to China in 2024, according to the Office of the U.S. Trade Representative. Of that $144 billion, $125 billion was products grown, produced or ...

Drug firms Glenmark and Biocon are recalling products in the US for manufacturing issues, according to the US health regulator. New Jersey-based Glenmark Pharmaceuticals Inc is recalling 8,160 bottles ...